These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15988919)

  • 1. [Possibilities in the treatment of primary biliary cirrhosis].
    Lengyel G; Tulassay Z
    Orv Hetil; 2005 Jun; 146(23):1245-9. PubMed ID: 15988919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
    Silveira MG; Lindor KD
    Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bezafibrate treatment: a new medical approach for PBC patients?
    Kanda T; Yokosuka O; Imazeki F; Saisho H
    J Gastroenterol; 2003; 38(6):573-8. PubMed ID: 12825134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Possible treatment modalities of primary sclerosing cholangitis].
    Lengyel G; Tulassay Z
    Orv Hetil; 2005 Dec; 146(49):2479-83. PubMed ID: 16398312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary biliary cirrhosis].
    Kuiper EM; den Ouden-Muller JW; van Buuren HR
    Ned Tijdschr Geneeskd; 2009; 153():A483. PubMed ID: 19900324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of primary biliary cirrhosis.
    Poupon R; Poupon RE
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):615-28. PubMed ID: 10976018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Therapies on Primary Biliary Cirrhosis.
    Czul F; Levy C
    Clin Liver Dis; 2016 Feb; 20(1):113-30. PubMed ID: 26593294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines.
    Heathcote EJ
    Hepatology; 2000 Apr; 31(4):1005-13. PubMed ID: 10733559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
    Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH
    Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New weapon for primary biliary cirrhosis from Japan.
    Zeniya M
    J Gastroenterol; 2003; 38(6):619-20. PubMed ID: 12858848
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary biliary cirrhosis and bile acids.
    Corpechot C
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S13-20. PubMed ID: 23141888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of primary biliary cirrhosis.
    Nishio A; Keeffe EB; Ishibashi H; Gershwin EM
    Med Sci Monit; 2000; 6(1):181-93. PubMed ID: 11208308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Eosinophilia in primary biliary cirrhosis: regression under therapy with ursodeoxycholic acid].
    Wirth HP; Meyenberger C; Altorfer J; Ammann R; Blum HE
    Schweiz Med Wochenschr; 1994 May; 124(19):810-5. PubMed ID: 8209204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary sclerosing cholangitis and primary biliary cirrhosis. How effective is medical therapy?
    Fennerty MB
    Postgrad Med; 1993 Nov; 94(6):81-8; 92. PubMed ID: 8234100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of autoimmune and cholestatic liver disorders.
    Krok KL; Munoz SJ
    Clin Liver Dis; 2009 May; 13(2):295-316. PubMed ID: 19442920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophilia in primary biliary cirrhosis.
    Yamazaki K; Nakadate I; Suzuki K; Sato S; Masuda T
    Am J Gastroenterol; 1996 Mar; 91(3):516-22. PubMed ID: 8633501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid.
    Abbas G; Lindor KD
    Expert Opin Pharmacother; 2010 Feb; 11(3):387-92. PubMed ID: 20102304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of decreased nitrite production by bezafibrate in patients with primary biliary cirrhosis.
    Akbar SM; Furukawa S; Nakanishi S; Abe M; Horiike N; Onji M
    J Gastroenterol; 2005 Feb; 40(2):157-63. PubMed ID: 15770399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Chazouillères O; Wendum D; Serfaty L; Rosmorduc O; Poupon R
    J Hepatol; 2006 Feb; 44(2):400-6. PubMed ID: 16356577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.